Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09RJN
|
||||
Former ID |
DIB004393
|
||||
Drug Name |
S-17092-1
|
||||
Synonyms |
S-17092 (undefined isomer); (2S,3aS,7aS)-1-[(1R,2R)-2-Phenylcyclopropylcarbonyl]-2-(thiazolidin-3-ylcarbonyl)perhydroindole
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cognitive disorders [ICD9: 290-294, 294.0, 780.09, 780.9, 780.93; ICD10:F01-F07, F04, F05, R41.3] | Phase 1 | [546918] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H28N2O2S
|
||||
Canonical SMILES |
C1CCC2C(C1)CC(N2C(=O)C3CC3C4=CC=CC=C4)C(=O)N5CCSC5
|
||||
InChI |
1S/C22H28N2O2S/c25-21(18-13-17(18)15-6-2-1-3-7-15)24-19-9-5-4-8-16(19)12-20(24)22(26)23-10-11-27-14-23/h1-3,6-7,16-20H,4-5,8-14H2/t16-,17-,18+,19-,20-/m0/s1
|
||||
InChIKey |
NXSXRIHXEQSYEZ-KNJMJIDISA-N
|
||||
CAS Number |
CAS 176797-26-5
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Prolyl endopeptidase | Target Info | Inhibitor | [526549] | |
KEGG Pathway | Renin-angiotensin system | ||||
PANTHER Pathway | Vasopressin synthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.